The Chief Executive Officer (CEO) of the Medicinal Cannabis Authority participated in the opening consultations on Antigua and Barbuda's new Pharmacy Bill, emphasizing the need to resolve conflicts between existing pharmacy regulations and medicinal cannabis legislation.
Regis Burton explained that his presence at the Parliament Building was necessary due to overlaps between the Pharmacy Act and the work of the Medicinal Cannabis Authority (MCA), particularly given that the current Pharmacy Regulations were last amended in 2012.
"I am here representing the Medicinal Cannabis Authority, where there is some level of overlap between what happens at the Pharmacy Act and the Pharmacy Regulations," Burton said. The CEO emphasized the importance of incorporating advances in cannabis science into the updated pharmaceutical regulations, noting that the MCA serves as the central regulatory body for medicinal cannabis in the country.
"It's important that as the development within the pharmaceutical industry advances, the inclusion of the new knowledge, the new science of medicinal cannabis, is also incorporated," he stated. "So I am here today to ensure that, as a professional in the industry, I can share some of the developments in the cannabis industry that they may not be too familiar with."
Read more at The Antigua Observer
